Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2600 of 3546 entries
View as:

Study Of Lapatinib In Patients With Relapsed Or Refractory Inflammatory Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00105950 Org: User:
Start: 03/31/05 End: 05/31/10 Due: 05/31/11

A Clinical Study Assessing Critical Errors, Training/Teaching Time, and Preference Attributes of the ELLIPTA® Dry Powder Inhaler, in Comparison to Combinations of Dry Powder Inhalers Used to Provide Triple Therapy, in Patients With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT02982187 Org: User:
Start: 12/30/16 End: 06/19/17 Due: 06/19/18

A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772

Phase: N/A Priority: Normal
NCT ID: NCT03649412 Org: User:
Start: 09/26/18 End: 05/07/19 Due: 05/07/20

Tafenoquine/Chloroquine DDI Study

Phase: N/A Priority: Normal
NCT ID: NCT00871156 Org: User:
Start: 03/24/09 End: 08/26/09 Due: 08/26/10

Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children Aged 10 to Less Than 18 Years

Phase: N/A Priority: Normal
NCT ID: NCT01035749 Org: User:
Start: 02/01/10 End: 05/10/11 Due: 05/10/12

A Safety and Tolerability Study of GSK2982772, in Single (in Both Fed and Fasted States) and Repeat Oral Doses in Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02302404 Org: User:
Start: 01/06/15 End: 03/05/16 Due: 03/05/17

Revaccination With Influenza Vaccine GSK1247446A

Phase: N/A Priority: Normal
NCT ID: NCT00545025 Org: User:
Start: 10/15/07 End: 12/12/07 Due: 12/12/08

To Investigate the Safety, Pharmacodynamics and Effect on Allergic Reactivity of the Toll-like Receptor 7 (TLR7) Agonist GSK2245035 in Subjects With Respiratory Allergies

Phase: N/A Priority: Normal
NCT ID: NCT01788813 Org: User:
Start: 03/31/13 End: 08/31/14 Due: 08/31/15

To Evaluate the Efficacy of an Experimental Dissolvable Strip in Rapidly Relieving Dentinal Hypersensitivity (DH)

Phase: N/A Priority: Normal
NCT ID: NCT02937623 Org: User:
Start: 11/21/16 End: 12/22/16 Due: 12/22/17

Study to Demonstrate the Bioequivalence of the Fixed Dose Combination of COREG CR™ and Lisinopril to Its Components

Phase: N/A Priority: Normal
NCT ID: NCT00556920 Org: User:
Start: 10/31/07 End: 12/31/07 Due: 12/31/08

Assessment of the Cosmetic Benefit of a Skin Cream in Healthy Females With Mild to Advanced Photo-damaged Facial Skin Who Have Undergone a Glycolic Acid Facial Peel Procedure

Phase: N/A Priority: Normal
NCT ID: NCT03197883 Org: User:
Start: 07/17/17 End: 10/31/17 Due: 10/31/18

Study In Asthma Control

Phase: N/A Priority: Normal
NCT ID: NCT00273026 Org: User:
Start: 11/08/04 End: 03/28/06 Due: 03/28/07

The Effect of Paracetamol, Pseudoephedrine Hydrochloride, Dextromethorphan Hydrobromide and Chlorpheniramine Maleate Tablets Compared to Placebo in Subjects Suffering From the Common Cold or Influenza.

Phase: N/A Priority: Normal
NCT ID: NCT02246166 Org: User:
Start: 01/31/15 End: 02/28/15 Due: 02/28/16

A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

Phase: N/A Priority: Normal
NCT ID: NCT06213506 Org: User:
Start: 01/15/24 End: 04/27/26 Due: 04/27/27

An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00057239 Org: User:
Start: 03/31/03 End: 05/31/04 Due: 05/31/05

SB-743921 In Patients With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00136513 Org: User:
Start: 04/30/04 End: - Due: -

Efficacy and Safety of Depemokimab Compared With Mepolizumab in Adults With Relapsing or Refractory Eosinophilic Granulomatosis With Polyangiitis (EGPA)

Phase: N/A Priority: Normal
NCT ID: NCT05263934 Org: User:
Start: 07/14/22 End: 11/24/26 Due: 11/24/27

Bioequivalence Trial of Alprazolam 0.5 mg Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01745562 Org: User:
Start: 12/07/10 End: 12/17/10 Due: 12/17/11

Study to Assess the Safety of a New GSK Biologicals' GSK2231395A Candidate Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00849069 Org: User:
Start: 03/12/09 End: 04/07/09 Due: 04/07/10

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

Phase: N/A Priority: Normal
NCT ID: NCT00610168 Org: User:
Start: 01/01/08 End: 04/30/08 Due: 04/30/09

Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT00169455 Org: User:
Start: 03/31/05 End: 12/31/05 Due: 12/31/06

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

Phase: N/A Priority: Normal
NCT ID: NCT03128489 Org: User:
Start: 12/01/17 End: 08/01/18 Due: 08/01/19

First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)

Phase: N/A Priority: Normal
NCT ID: NCT03666988 Org: User:
Start: 10/22/18 End: 03/04/21 Due: 03/04/22

Intravenous Microdose Pharmacokinetic (PK) Study With [14C]-GSK2239633

Phase: N/A Priority: Normal
NCT ID: NCT01086462 Org: User:
Start: 01/21/10 End: 02/22/10 Due: 02/22/11

A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Phase: N/A Priority: Normal
NCT ID: NCT01178073 Org: User:
Start: 10/01/10 End: 07/31/14 Due: 07/31/15